The immunoregulatory protein human B7H3 is a tumor-associated antigen that regulates tumor cell migration and invasion

Current Cancer Drug Targets

Volumn 8, Issue 5, 2008, Pages 404-413

  Chen, Yih Wen ^a   Tekle, Christina ^b,c   Fodstad, Øystein ^a,b,c  

^a UNIVERSITY OF SOUTH ALABAMA   (United States)

^b OSLO UNIVERSITY HOSPITAL   (Norway)

^c UNIVERSITY OF OSLO   (Norway)

Author keywords

376.96 mAb; Adhesion; Human B7H3; Invasion; Metastasis; Migration; Tumor progression; Tumor associated antigen

Indexed keywords

B7H3 PROTEIN; FIBRONECTIN; IMMUNOREGULATORY PROTEIN; MEMBRANE PROTEIN; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY 376.96; PHORBOL 13 ACETATE 12 MYRISTATE; SMALL INTERFERING RNA; TUMOR ANTIGEN; TUNICAMYCIN;

ANTIGEN BINDING; ANTIGEN RECOGNITION; ARTICLE; BINDING ASSAY; BREAST CANCER; CANCER CELL CULTURE; CARCINOGENESIS; CELL ADHESION; CELL ASSAY; CELL FRACTIONATION; CELL INVASION; CELL LYSATE; CELL MIGRATION; CELL PROLIFERATION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DIAGNOSTIC VALUE; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IMMUNOPRECIPITATION; MELANOMA CELL; METASTASIS; OSTEOSARCOMA CELL; PROGNOSIS; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; REGULATORY MECHANISM; TUMOR CELL; TUMOR GROWTH;

ANTIGENS, CD; ANTIGENS, NEOPLASM; ANTIVIRAL AGENTS; BINDING, COMPETITIVE; BLOTTING, WESTERN; CELL ADHESION; CELL MOVEMENT; CELL PROLIFERATION; COLLAGEN; DRUG COMBINATIONS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FIBRONECTINS; FLOW CYTOMETRY; GLYCOSYLATION; HUMANS; IMMUNOPRECIPITATION; LAMININ; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; NEOPLASMS; PROTEOGLYCANS; RECEPTORS, IMMUNOLOGIC; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; RNA, SMALL INTERFERING; SUBCELLULAR FRACTIONS; TETRADECANOYLPHORBOL ACETATE; TUMOR CELLS, CULTURED; TUNICAMYCIN;

EID: 48849090862     PISSN: 15680096     EISSN: None     Source Type: Journal    
DOI: 10.2174/156800908785133141     Document Type: Article

References (38)

1. Brackenbury, R. Molecular mechanisms of cell adhesion in normal and transformed cells. Cancer Metastasis Rev. 1985, 4, 41-58.
2. Merimsky, O.; Shoenfeld, Y.; Chaitchik, S.; Yecheskel, G.; Fishman, P. Antigens and antibodies in malignant melanoma. Tumour Biol. 1994, 15, 188-202.
3. Streit, M.; Detmar, M. Angiogenesis, lymphangiogenesis, and melanoma metastasis. Oncogene 2003, 22, 3172-3179.
4. Miller, A. J.; Mihm, M. C., Jr. Melanoma. N. Engl. J. Med. 2006, 355, 51-65.
5. Seeger, R. C.; Rosenblatt, H. M.; Imai, K.; Ferrone, S. Common antigenic determinants on human melanoma, glioma, neuroblastoma, and sarcoma cells defined with monoclonal antibodies. Cancer Res. 1981, 41, 2714-2717.
6. Imai, K.; Galloway, D. R.; Ferrone, S. Serological and immunochemical analysis of the specificity of xenoantiserum 8986 elicited with hybrids between human melanoma cells and murine fibroblasts. Cancer Res. 1981, 41, 1028-1033.
7. Natali, P. G.; Giacomini, P.; Bigotti, A.; Imai, K.; Nicotra, M. R.; Ng, A. K.; Ferrone, S. Heterogeneity in the expression of HLA and tumor-associated antigens by surgically removed and cultured breast carcinoma cells. Cancer Res. 1983, 43, 660-668.
8. Fodstad, O.; Faye, R.; Hoifodt, H. K.; Skovlund, E.; Aamdal, S. Immunobead-based detection and characterization of circulating tumor cells in melanoma patients. Recent Results Cancer Res. 2001, 158, 40-50.
9. Faye, R. S.; Aamdal, S.; Hoifodt, H. K.; Jacobsen, E.; Holstad, L.; Skovlund, E.; Fodstad, O. Immunomagnetic detection and clinical significance of micrometastatic tumor cells in malignant melanoma patients. Clin. Cancer Res. 2004, 10, 4134-4139.
10. Chatterjee, S. K.; Zetter, B. R. Cancer biomarkers: knowing the present and predicting the future. Future Oncol. 2005, 1, 37-50.
11. Torabian, S., Kashani-Sabet, M. Biomarkers for melanoma. Curr. Opin. Oncol. 2005, 17, 167-171.
12. Burchiel, S. W.; Martin, J. C.; Imai, K.; Ferrone, S.; Warner, N. L. Heterogeneity of HLA-A,B, Ia-like, and melanoma-associated antigen expression by human melanoma cell lines analyzed with monoclonal antibodies and flow cytometry. Cancer Res. 1982, 42, 4110-4115.
13. Rosenberg, C. D.; Ferrone, S.; Hamby, C. V.; Mancino, V.; Graf, L. H. Jr. Interspecific DNA-mediated transfer and amplification of a gene specifying a Mr 100,000 human melanoma-associated cell surface glycoprotein. Cancer Res. 1990, 50, 1559-1565.
14. Tveito, S.; Maelandsmo, G. M.; Hoifodt, H. K.; Rasmussen, H.; Fodstad, O. Specific isolation of disseminated cancer cells - a new method permitting sensitive detection of target molecules of diagnostic and therapeutic value. Clin. Exp. Metastasis 2007, 24, 317-327.
15. Chapoval, A. I.; Ni, J.; Lau, J. S.; Wilcox, R. A.; Flies, D. B.; Liu, D.; Dong, H.; Sica, G. L.; Zhu, G.; Tamada, K.; Chen, L. B7-H3: a costimulatory molecule for T cell activation and IFN-gamma production. Nat. Immunol. 2001, 2, 269-274.
16. Sun, M.; Richards, S.; Prasad, D. V.; Mai, X. M.; Rudensky, A.; Dong, C. Characterization of mouse and human B7-H3 genes. J. Immunol. 2002, 168, 6294-6297.
17. Ling, V.; Wu, P. W.; Spaulding, V.; Kieleczawa, J.; Luxenberg, D.; Carreno, B. M.; Collins, M. Duplication of primate and rodent B7-H3 immunoglobulin V- and C-like domains: divergent history of functional redundancy and exon loss. Genomics 2003, 82, 365-377.
18. Steinberger, P.; Majdic, O.; Derdak, S. V.; Pfistershammer, K.; Kirchberger, S.; Klauser, C.; Zlabinger, G.; Pickl, W. F.; Stockl, J.; Knapp, W. Molecular characterization of human 4Ig-B7-H3, a member of the B7 family with four Ig-like domains. J. Immunol. 2004, 172, 2352-2359.
19. Sun, X.; Vale, M.; Leung, E.; Kanwar, J. R.; Gupta, R.; Krissansen, G. W. Mouse B7-H3 induces antitumor immunity. Gene Ther. 2003, 10, 1728-1734.
20. Luo, L.; Chapoval, A. I.; Flies, D. B.; Zhu, G.; Hirano, F.; Wang, S.; Lau, J. S.; Dong, H.; Tamada, K.; Flies, A. S.; Liu, Y.; Chen, L. B7-H3 enhances tumor immunity in vivo by costimulating rapid clonal expansion of antigen-specific CD8+ cytolytic T cells. J. Immunol. 2004, 173, 5445-5450.
21. Zhang, G. B.; Chen, Y. J.; Shi, Q.; Ma, H. B.; Ge, Y.; Wang, Q.; Jiang, Z.; Xu, Y.; Zhang, X. G. Human recombinant B7-H3 expressed in E. coli enhances T lymphocyte proliferation and IL-10 secretion in vitro. Acta Biochim. Biophys. Sin. (Shanghai). 2004, 36, 430-436.
22. Suh, W. K.; Gajewska, B. U.; Okada, H.; Gronski, M. A.; Bertram, E. M.; Dawicki, W.; Duncan, G. S.; Bukczynski, J.; Plyte, S.; Elia, A.; Wakeham, A.; Itie, A.; Chung, S.; Da Costa, J.; Arya, S.; Horan, T.; Campbell, P.; Gaida, K.; Ohashi, P. S.; Watts, T. H.; Yoshinaga, S. K.; Bray, M. R.; Jordana, M.; Mak, T. W. The B7 family member B7-H3 preferentially down-regulates T helper type 1-mediated immune responses. Nat. Immunol. 2003, 4, 899-906.
23. Castriconi, R.; Dondero, A.; Augugliaro, R.; Cantoni, C.; Carnemolla, B.; Sementa, A. R.; Negri, F; Conte, R.; Corrias, M. V.; Moretta, L.; Moretta, A.; Bottino, C. Identification of 4Ig-B7-H3 as a neuroblastoma-associated molecule that exerts a protective role from an NK cell-mediated lysis. Proc. Natl. Acad. Sci. USA, 2004, 101, 12640-12645.
24. Sun, Y.; Wang, Y.; Zhao, J.; Gu, M.; Giscombe, R.; Lefvert, A. K.; Wang, X.; B7-H3 and B7-H4 expression in non-small-cell lung cancer. Lung Cancer 2006, 53, 143-151.
25. Zhang, G. B.; Zhou, H.; Chen, Y. J.; Ge, Y.; Xie, F.; Shi, Q.; Ma, H. B.; Fei, M.; Zhang, X. G. Characterization and application of two novel monoclonal antibodies against 2IgB7-H3: expression analysis of 2IgB7-H3 on dendritic cells and tumor cells. Tissue Antigens 2005, 66, 83-92.
26. Wu, C. P.; Jiang, J. T.; Tan, M.; Zhu, Y. B.; Ji, M.; Xu, K. F.; Zhao, J. M.; Zhang, G. B.; Zhang, X. G. Relationship between co-stimulatory molecule B7-H3 expression and gastric carcinoma histology and prognosis. World J. Gastroenterol. 2006, 12, 457-459.
27. Luo, L.; Qiao, H.; Meng, F.; Dong, X.; Zhou, B.; Jiang, H.; Kanwar, J. R.; Krissansen, G. W.; Sun, X. Arsenic trioxide synergizes with B7H3-mediated immunotherapy to eradicate hepatocellular carcinomas. Int. J. Cancer 2006, 118, 1823-1830.
28. Fodstad, O.; Kjonniksen, I.; Aamdal, S.; Nesland, J. M.; Boyd, M. R.; Pihl, A. Extrapulmonary, tissue-specific metastasis formation in nude mice injected with FEMX-I human melanoma cells. Cancer Res. 1988, 48, 4382-4388.
29. Rye, P. D.; Norum, L.; Olsen, D. R.; Garman-Vik, S.; Kaul, S.; Fodstad, O. Brain metastasis model in athymic nude mice using a novel MUC1-secreting human breast-cancer cell line, MA11. Int. J. Cancer 1996, 68, 682-687.
30. Fodstad, O.; Brogger, A.; Bruland, O.; Solheim, O. P.; Nesland, J. M.; Pihl, A. Characteristics of a cell line established from a patient with multiple osteosarcoma, appearing 13 years after treatment for bilateral retinoblastoma. Int. J. Cancer 1986, 38, 33-40.
31. Chen, Y. W.; Lang, M. L.; Wade, W. F. Protein kinase C-alpha and -delta are required for FcalphaR (CD89) trafficking to MHC class II compartments and FcalphaR-mediated antigen presentation. Traffic 2004, 5, 577-594.
32. Sottile, J.; Hocking, D. C.; Langenbach, K. J. Fibronectin polymerization stimulates cell growth by RGD-dependent and -independent mechanisms. J. Cell Sci. 2000, 113, 4287-4299.
33. Valster, A., Tran, N. L.; Nakada, M.; Berens, M. E.; Chan, A. Y.; Symons, M. Cell migration and invasion assays. Methods 2005, 37, 208-215.
34. Carreno, B. M., Collins, M. The B7 family of ligands and its receptors: new pathways for costimulation and inhibition of immune responses. Annu. Rev. Immunol. 2002, 20, 29-53.
35. Chen, L. Co-inhibitory molecules of the B7-CD28 family in the control of T-cell immunity. Nat. Rev. Immunol. 2004, 4, 336-347.
36. Egawa, N.; Koshikawa, N.; Tomari, T.; Nabeshima, K.; Isobe, T.; Seiki, M. Membrane-type-1 matrix metalloproteinase (MT1-MMP/MMP-14) cleaves and releases a 22-KDA EMMPRIN fragment from tumor cells. J. Biol. Chem. 2006, 281, 37576-37585.
37. Moh, M. C.; Zhang, C.; Luo, C.; Lee, L. H.; Shen, S. Structural and functional analyses of a novel ig-like cell adhesion molecule, hepaCAM, in the human breast carcinoma MCF7 cells. J. Biol. Chem. 2005, 280, 27366-27374.
38. Suyama, K.; Shapiro, I.; Guttman, M.; Hazan, R. B. A signaling pathway leading to metastasis is controlled by N-cadherin and the FGF receptor. Cancer Cell 2002, 2, 301-314.